The paper provides transparency into how the database collects and processes the research it compiles, insights into the design of its graphical user interface, as well as the database’s strengths and limitations.
The Global Organization for EPA and DHA Omega-3s (GOED) has announced the publication of a peer-reviewed article detailing the methodology of its newly developed Clinical Study Database. The comprehensive, manually curated database catalogs the wealth of research on the effects of EPA and DHA. Despite the amount of research on the subject, with 200-250 new articles indexed by PubMed each month, there remains significant gaps in the understanding of EPA and DHA’s health effects. The database would aid researchers in conducting systematic investigations to identify or resolve these gaps.
The paper published in Prostaglandins, Leukotrienes and Essential Fatty Acids1 provides transparency into how the database collects and processes the research it compiles, insights into the design of its graphical user interface, as well as the database’s strengths and limitations.
“We believe that having a peer-reviewed publication detailing the CSD methodology improves the credibility of the database,” said Aldo Bernasconi, PhD, vice president of data science for GOED and lead developer of the Clinical Study Database, in a press release. “We hope that by validating and describing our data extraction and processing methods, scientists will be more inclined to trust the tool and employ it as part of their research-gathering.”
Access to the database is through an annual or quarterly subscription model, with additional options to commission an individual concierge report of a specific project need. GOED members receive discounted pricing. Inquiries can be directed to Kaitlin Roke, PhD.